Kaniel Cassady

1.1k total citations
26 papers, 624 citations indexed

About

Kaniel Cassady is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Kaniel Cassady has authored 26 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 15 papers in Immunology and 10 papers in Oncology. Recurrent topics in Kaniel Cassady's work include Hematopoietic Stem Cell Transplantation (10 papers), Immune Cell Function and Interaction (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Kaniel Cassady is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Immune Cell Function and Interaction (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Kaniel Cassady collaborates with scholars based in United States and China. Kaniel Cassady's co-authors include Defu Zeng, Yimei Feng, Xi Zhang, Zhongmin Zou, Paul J. Martin, Mingfeng Zhang, Ruishu Deng, Xiaoping Li, Monika D. Polewski and Karen S. Aboody and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Blood.

In The Last Decade

Kaniel Cassady

25 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaniel Cassady United States 12 271 253 198 173 85 26 624
Brooke Snetsinger Canada 8 175 0.6× 242 1.0× 287 1.4× 104 0.6× 92 1.1× 18 664
Claudiu Cotta United States 16 126 0.5× 182 0.7× 294 1.5× 133 0.8× 44 0.5× 50 638
Piera La Cava Italy 15 280 1.0× 247 1.0× 223 1.1× 222 1.3× 43 0.5× 36 634
Antonia Reale Italy 13 94 0.3× 217 0.9× 315 1.6× 198 1.1× 112 1.3× 32 560
Jennifer Adelsperger United States 5 222 0.8× 444 1.8× 417 2.1× 101 0.6× 67 0.8× 6 793
Kira Young United States 11 188 0.7× 302 1.2× 316 1.6× 87 0.5× 79 0.9× 21 664
Giuseppe Celesti Italy 12 199 0.7× 122 0.5× 120 0.6× 300 1.7× 81 1.0× 16 551
M. M. Uttenreuther-Fischer Germany 13 143 0.5× 101 0.4× 201 1.0× 198 1.1× 67 0.8× 24 542
Chung Hoow Kok Australia 17 116 0.4× 454 1.8× 338 1.7× 153 0.9× 72 0.8× 68 800
Philip G. Hargreaves United Kingdom 8 130 0.5× 323 1.3× 126 0.6× 86 0.5× 110 1.3× 12 608

Countries citing papers authored by Kaniel Cassady

Since Specialization
Citations

This map shows the geographic impact of Kaniel Cassady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaniel Cassady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaniel Cassady more than expected).

Fields of papers citing papers by Kaniel Cassady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaniel Cassady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaniel Cassady. The network helps show where Kaniel Cassady may publish in the future.

Co-authorship network of co-authors of Kaniel Cassady

This figure shows the co-authorship network connecting the top 25 collaborators of Kaniel Cassady. A scholar is included among the top collaborators of Kaniel Cassady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaniel Cassady. Kaniel Cassady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Benjamin, John D. Minna, David E. Gerber, et al.. (2025). SARS-CoV-2 vaccine failure rates and predictors of immune response in a diverse immunocompromised patient population. Vaccine. 62. 127473–127473.
2.
Li, Qinjian, Xiaoqi Wang, Qingxiao Song, et al.. (2023). Donor T cell STAT3 deficiency enables tissue PD-L1–dependent prevention of graft-versus-host disease while preserving graft-versus-leukemia activity. Journal of Clinical Investigation. 133(15). 5 indexed citations
3.
Feng, Yimei, Ting Chen, Ping Wang, et al.. (2023). Azacitidine and lenalidomide combination: a novel relapse prophylaxis regimen after allogeneic hematopoietic stem-cell transplantation in patients with acute myeloid leukemia. Frontiers in Immunology. 14. 1182251–1182251. 2 indexed citations
4.
Zhang, Yun, Dan Wang, Kaniel Cassady, et al.. (2023). Optimizing the therapeutic window of sirolimus by monitoring blood concentration for the treatment of immune thrombocytopenia. Platelets. 34(1). 2277831–2277831. 3 indexed citations
5.
6.
Wang, Wei-Le, Ching Ouyang, Kaniel Cassady, et al.. (2022). microRNA-142 guards against autoimmunity by controlling Treg cell homeostasis and function. PLoS Biology. 20(2). e3001552–e3001552. 13 indexed citations
7.
Kong, Xiaohui, Xiwei Wu, Kaniel Cassady, et al.. (2022). Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD. Blood. 140(25). 2740–2753. 8 indexed citations
8.
Chen, Xiaoli, Hengrui Sun, Kaniel Cassady, et al.. (2021). The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety. Frontiers in Oncology. 11. 683263–683263. 11 indexed citations
9.
10.
Feng, Yimei, Xiaoli Chen, Kaniel Cassady, et al.. (2021). The Role of mTOR Inhibitors in Hematologic Disease: From Bench to Bedside. Frontiers in Oncology. 10. 611690–611690. 35 indexed citations
11.
Feng, Yimei, Ping Wang, Wen Zhu, et al.. (2020). Sirolimus as Rescue Therapy for Refractory/Relapsed Immune Thrombocytopenia: Results of a Single-Center, Prospective, Single-Arm Study. Frontiers in Medicine. 7. 110–110. 31 indexed citations
12.
Feng, Yimei, Xiaoping Li, Kaniel Cassady, Zhongmin Zou, & Xi Zhang. (2019). TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair. Frontiers in Oncology. 9. 210–210. 84 indexed citations
13.
Cassady, Kaniel, Paul J. Martin, & Defu Zeng. (2018). Regulation of GVHD and GVL Activity via PD-L1 Interaction With PD-1 and CD80. Frontiers in Immunology. 9. 3061–3061. 31 indexed citations
14.
Jin, Hua, Xiong Ni, Ruishu Deng, et al.. (2016). Antibodies from donor B cells perpetuate cutaneous chronic graft-versus-host disease in mice. Blood. 127(18). 2249–2260. 67 indexed citations
15.
Polewski, Monika D., et al.. (2016). Increased Expression of System xc− in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance. Molecular Cancer Research. 14(12). 1229–1242. 101 indexed citations
16.
Wu, Limin, Mingfeng Zhang, Shengli Xue, et al.. (2015). MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice. Proceedings of the National Academy of Sciences. 112(52). 15994–15999. 12 indexed citations
17.
18.
Deng, Ruishu, Kaniel Cassady, Xiaofan Li, et al.. (2014). B7H1/CD80 Interaction Augments PD-1–Dependent T Cell Apoptosis and Ameliorates Graft-versus-Host Disease. The Journal of Immunology. 194(2). 560–574. 58 indexed citations
19.
Johnston, Heather F, Jeremy J. Racine, Kaniel Cassady, et al.. (2014). Administration of Anti-CD20 mAb Is Highly Effective in Preventing but Ineffective in Treating Chronic Graft-Versus-Host Disease While Preserving Strong Graft-Versus-Leukemia Effects. Biology of Blood and Marrow Transplantation. 20(8). 1089–1103. 28 indexed citations
20.
He, Wei, Jeremy J. Racine, Heather F Johnston, et al.. (2014). Depletion of Host CCR7+ Dendritic Cells Prevented Donor T Cell Tissue Tropism in Anti-CD3–Conditioned Recipients. Biology of Blood and Marrow Transplantation. 20(7). 920–928. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brooke Snetsinger Breakdown of academic impact, for papers by Claudiu Cotta Breakdown of academic impact, for papers by Piera La Cava Breakdown of academic impact, for papers by Antonia Reale Breakdown of academic impact, for papers by Jennifer Adelsperger Breakdown of academic impact, for papers by Kira Young Breakdown of academic impact, for papers by Giuseppe Celesti Breakdown of academic impact, for papers by M. M. Uttenreuther-Fischer Breakdown of academic impact, for papers by Chung Hoow Kok Breakdown of academic impact, for papers by Philip G. Hargreaves
Rankless by CCL
2026